These are boom times for gene therapy, an innovative type of medicine that works to treat disease at the genetic level to offer a longer-lasting treatment and potentially even a cure.
BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that it had concluded both algorithm development and clinical validation studies in adolescent and young adult populations using its objective, EEG-based technology. The purpose of the studies was to create and validate an objective, personalized capability for assessment of concussion and readiness to return to activities in males and females between the ages of 13-25. The studies conducted from 2015 through 2019 at 52 clinical sites included nearly 1,700 patients and healthy controls, with over 4,000 evaluations. Funding sources for the studies included a $9.9 million research contract from the U.S. Department of Defense, award funding from the NFL-GE Head Health Challenge (in which BrainScope was a two-time awardee), and BrainScope private funding.
Outside of the private sector, colleges and universities perform the vast majority of R&D in the United States – but where do these funds come from? An SSTI analysis of data from the National Science Foundation’s National Center for Science and Engineering Statistics (NSF NCSES) finds that, across the country, the federal government was the source of more than half (53.5 percent) of all R&D performed at colleges and universities in 2017. Institutional funds (25.1 percent), nonprofit organizations (6.8 percent), businesses (5.9 percent), state and local governments (5.6 percent), and other sources (3.0 percent) comprised the remaining sources of higher education R&D funding. The interactive chart below shows the breakdown of funding sources for research and development at colleges and universities for each state.
Thursday, July 19, 20184:30 – 7:00 PM EST
Spend an inspiring 10 minute ‘ideastorming’ session with the some of the most influential innovation leaders in the greater Baltimore area. To schedule a session with one of our experts, please complete the application (in addition to the event registration) at www.anchorventures.org.
Join us today as we speak with Dr. Kurt Newman from Children’s National Health System about innovations in pediatrics.
Fina Biosolutions is pleased to announce that the Serum Institute of India Private Limited (SIIPL), has completed a Phase 3 study for Pneumosil® a 10-valent pneumococcal conjugate vaccine, in which the Serum Institute indicates all primary and secondary objectives were met. Pneumosil covers over 70% of invasive pneumococcal-disease causing serotypes and employs conjugation chemistry licensed from Fina Biosolutions under a 2007 technology agreement.
Last week, the Greater Washington Partnership (the Partnership) and Business Roundtable (BRT) held an event showcasing the Capital CoLAB (Collaborative of Leaders in Academia and Business). The Capital CoLAB is an action-oriented partnership of university and business leaders across the Capital Region, from Baltimore to Richmond, who have come together to position the region as a leading global hub for innovation.
A company that makes products for science researchers has bought one of the largest contract manufacturers of viral vectors for gene therapy.
Successful Marketing and PR Strategies for Your Startup
- PR and Marketing – What’s the difference?
- How do you establish your brand?
- Are there tips for marketing on a tight budget?
- How do we become known as an Employer of Choice?
- How can I become known as a Thought Leader in my field?
- How do we get press coverage for our products/service/technology?
- What should we budget for our website, social media, PR activities?
SPEAKERS
- Sasha Whitaker – American Gene Technologies
- Warren Ellis – Montgomery County Economic Dev. Corp.
- Jennifer Owers and Rachel Wojnilower – Clark Concepts
SCHEDULE
- 8:15 a.m. – Networking and Coffee
- 8:30 a.m. – Discussion with Q&A (in person/by videoconference)
- 9:45 a.m. – One-on-One Meetings with Experts*
Pre-Registration REQUIRED: RSVP by NOON, 4/3 at tinyurl.com/BHIMktgPR2019
No charge to attend
*In person attendance during the discussion is required to participate in 1:1 meeting with experts.
We are excited to announce that Rich Bendis of BioHealth Innovation will be the keynote speaker at the 2019 Technology Showcase. Now in its third year, the Technology Showcase promises to be a “must attend” event for biotech stakeholders in Maryland/DC/VA region. Check out the event page to learn more about our keynote speaker and some of the great panel sessions that we have planned.
Make sure to reserve time on your calendar for the afternoon of Wednesday, June 12.
The 2019 Technology Showcase is a half-day event that will showcase technologies being developed at the NCI and the Frederick National Laboratory for Cancer Research (FNLCR) to encourage startup company formation, technology licensing and collaborations. Innovators, entrepreneurs, investors and business development professionals should attend.